Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
143.13
+3.00 (2.14%)
At close: Mar 9, 2026, 4:00 PM EDT
143.13
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:04 PM EDT

Insmed Revenue

In the year 2025, Insmed had annual revenue of $606.42M with 66.73% growth. Insmed had revenue of $263.84M in the quarter ending December 31, 2025, with 152.62% growth.

Revenue (ttm)
$606.42M
Revenue Growth
+66.73%
P/S Ratio
50.66
Revenue / Employee
$364,437
Employees
1,664
Market Cap
30.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.42M242.72M66.73%
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201311.50M--
Dec 31, 2012---
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.34B
Incyte5.14B
argenx SE4.25B
Genmab3.72B
Alnylam Pharmaceuticals3.71B
BioNTech SE3.70B
Royalty Pharma2.38B
Moderna1.94B
Revenue Rankings